{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:16:03Z","timestamp":1790486163310,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":1075,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1074\/jbc.m117.807396","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T03:14:03Z","timestamp":1504754043000},"page":"17449-17460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody"],"prefix":"10.1016","volume":"292","author":[{"given":"Jon A.","family":"Kenniston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy M.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janja","family":"Cosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris J.","family":"Kopacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison P.","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Comeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateri","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameson","family":"Bullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"TenHoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burt A.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M117.807396_bib1","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s00018-010-0318-6","article-title":"The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases","volume":"67","author":"Sesarman","year":"2010","journal-title":"Cell Mol. Life Sci"},{"key":"10.1074\/jbc.M117.807396_bib2","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.4049\/jimmunol.1403014","article-title":"FcRn: the architect behind the immune and nonimmune functions of IgG and albumin","volume":"194","author":"Pyzik","year":"2015","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M117.807396_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fimmu.2015.00176","article-title":"Fully human monoclonal antibody inhibitors of the neonatal fc receptor reduce circulating IgG in non-human primates","volume":"6","author":"Nixon","year":"2015","journal-title":"Front. Immunol"},{"key":"10.1074\/jbc.M117.807396_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/337184a0","article-title":"An Fc receptor structurally related to MHC class I antigens","volume":"337","author":"Simister","year":"1989","journal-title":"Nature"},{"key":"10.1074\/jbc.M117.807396_bib5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1097-2765(01)00230-1","article-title":"Crystal structure at 2.8 \u00c5 of an FcRn\/heterodimeric Fc complex: mechanism of pH-dependent binding","volume":"7","author":"Martin","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.M117.807396_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/19420862.2015.1008353","article-title":"The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity","volume":"7","author":"Abdiche","year":"2015","journal-title":"MAbs"},{"key":"10.1074\/jbc.M117.807396_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/13543780902832679","article-title":"Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders","volume":"18","author":"Castillo","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1074\/jbc.M117.807396_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M117.807396_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","article-title":"14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends","volume":"13","author":"Erkan","year":"2014","journal-title":"Autoimmun. Rev"},{"key":"10.1074\/jbc.M117.807396_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1515\/revneuro-2014-0021","article-title":"Targeting complement system to treat myasthenia gravis","volume":"25","author":"Huda","year":"2014","journal-title":"Rev. Neurosci"},{"key":"10.1074\/jbc.M117.807396_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5603\/AIT.2013.0002","article-title":"Complications in patients treated with plasmapheresis in the intensive care unit","volume":"45","author":"Szczeklik","year":"2013","journal-title":"Anaesthesiol. Intensive Ther"},{"key":"10.1074\/jbc.M117.807396_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ncpneuro0429","article-title":"Shortage of human intravenous immunoglobulin: reasons and possible solutions","volume":"3","author":"Bayry","year":"2007","journal-title":"Nat. Clin. Pract. Neurol"},{"key":"10.1074\/jbc.M117.807396_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/jaut.1999.0302","article-title":"In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration","volume":"13","author":"Kessary-Shoham","year":"1999","journal-title":"J. Autoimmun"},{"key":"10.1074\/jbc.M117.807396_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.186.5.777","article-title":"\u03b22-Microglobulin-deficient mice are resistant to bullous pemphigoid","volume":"186","author":"Liu","year":"1997","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.M117.807396_bib15","first-page":"1328","article-title":"The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease","volume":"113","author":"Akilesh","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M117.807396_bib16","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1073\/pnas.0708960105","article-title":"Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn","volume":"105","author":"Mezo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M117.807396_bib17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4049\/jimmunol.1003780","article-title":"Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model","volume":"187","author":"Patel","year":"2011","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M117.807396_bib18","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.4049\/jimmunol.178.8.5390","article-title":"Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade","volume":"178","author":"Liu","year":"2007","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M117.807396_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nbt1067","article-title":"Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity","volume":"23","author":"Hoet","year":"2005","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/jbc.M117.807396_bib20","doi-asserted-by":"crossref","first-page":"14649","DOI":"10.1021\/bi00045a005","article-title":"Analysis of the pH dependence of the neonatal Fc receptor\/immunoglobulin G interaction using antibody and receptor variants","volume":"34","author":"Raghavan","year":"1995","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M117.807396_bib21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4161\/mabs.28744","article-title":"Characterization and screening of IgG binding to the neonatal Fc receptor","volume":"6","author":"Neuber","year":"2014","journal-title":"MAbs"},{"key":"10.1074\/jbc.M117.807396_bib22","doi-asserted-by":"crossref","first-page":"9698","DOI":"10.1021\/bi000749m","article-title":"Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor","volume":"39","author":"West","year":"2000","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M117.807396_bib23","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1074\/jbc.M113.537563","article-title":"Structural insights into neonatal Fc receptor-based recycling mechanisms","volume":"289","author":"Oganesyan","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.807396_bib24","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.str.2013.08.022","article-title":"Crystal structure of an HSA\/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface","volume":"21","author":"Schmidt","year":"2013","journal-title":"Structure"},{"key":"10.1074\/jbc.M117.807396_bib25","doi-asserted-by":"crossref","first-page":"27694","DOI":"10.1074\/jbc.M110.120667","article-title":"X-ray crystal structures of monomeric and dimeric peptide inhibitors in complex with the human neonatal Fc receptor, FcRn","volume":"285","author":"Mezo","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.807396_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4939-3661-8_6","article-title":"Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies","volume":"1438","author":"Roopenian","year":"2016","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/jbc.M117.807396_bib27","doi-asserted-by":"crossref","first-page":"17228","DOI":"10.1074\/jbc.M113.522565","article-title":"Dissection of the neonatal Fc receptor (FcRn)-albumin interface using mutagenesis and anti-FcRn albumin-blocking antibodies","volume":"289","author":"Sand","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.807396_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncomms1607","article-title":"Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor","volume":"3","author":"Andersen","year":"2012","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.M117.807396_bib29","series-title":"Henry's Clinical Diagnosis and Management by Laboratory Methods","author":"McPherson","year":"2017"},{"key":"10.1074\/jbc.M117.807396_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4161\/mabs.3.5.16983","article-title":"Neonatal Fc receptor and IgG-based therapeutics","volume":"3","author":"Kuo","year":"2011","journal-title":"MAbs"},{"key":"10.1074\/jbc.M117.807396_bib31","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.4049\/jimmunol.169.9.5171","article-title":"Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences","volume":"169","author":"Dall'Acqua","year":"2002","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M117.807396_bib32","doi-asserted-by":"crossref","first-page":"23514","DOI":"10.1074\/jbc.M604292200","article-title":"Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)","volume":"281","author":"Dall'Acqua","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.807396_bib33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/nbt1143","article-title":"Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels","volume":"23","author":"Vaccaro","year":"2005","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/jbc.M117.807396_bib34","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1074\/jbc.M607161200","article-title":"Monoclonal antibody clearance: impact of modulating the interaction of IgG with the neonatal Fc receptor","volume":"282","author":"Datta-Mannan","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.807396_bib35","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc\u03b3 RI, Fc\u03b3RII, Fc\u03b3RIII, and FcRn and design of IgG1 variants with improved binding to the Fc\u03b3R","volume":"276","author":"Shields","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.807396_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199901213400311","article-title":"Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases","volume":"340","author":"Yu","year":"1999","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M117.807396_bib37","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood.V98.10.3136","article-title":"Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect","volume":"98","author":"Bleeker","year":"2001","journal-title":"Blood"},{"key":"10.1074\/jbc.M117.807396_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","article-title":"Intravenous immunoglobulin: an update on the clinical use and mechanisms of action","volume":"27","author":"Negi","year":"2007","journal-title":"J. Clin. Immunol"},{"key":"10.1074\/jbc.M117.807396_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/jbc.M117.807396_bib40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M117.807396_bib41","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/intimm\/dxl110","article-title":"Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease","volume":"18","author":"Petkova","year":"2006","journal-title":"Int. Immunol"},{"key":"10.1074\/jbc.M117.807396_bib42","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4161\/mabs.25439","article-title":"Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis","volume":"5","author":"Challa","year":"2013","journal-title":"MAbs"},{"key":"10.1074\/jbc.M117.807396_bib43","first-page":"81","article-title":"High-dose intravenous gammaglobulin therapy of refractory, in particular idiopathic thrombocytopenia in childhood","volume":"36","author":"Imbach","year":"1981","journal-title":"Helv. Paediatr. Acta"},{"key":"10.1074\/jbc.M117.807396_bib44","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM198205273062102","article-title":"Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous \u03b3 globulin","volume":"306","author":"Fehr","year":"1982","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M117.807396_bib45","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1182\/blood.V100.6.2087","article-title":"Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia","volume":"100","author":"Hansen","year":"2002","journal-title":"Blood"},{"key":"10.1074\/jbc.M117.807396_bib46","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2011-08-374223","article-title":"The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia","volume":"118","author":"Crow","year":"2011","journal-title":"Blood"},{"key":"10.1074\/jbc.M117.807396_bib47","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"10.1074\/jbc.M117.807396_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20061788","article-title":"The antiinflammatory activity of IgG: the intravenous IgG paradox","volume":"204","author":"Nimmerjahn","year":"2007","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.M117.807396_bib49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/BJ20090010","article-title":"Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases","volume":"422","author":"Sexton","year":"2009","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M117.807396_bib50","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.1175868","article-title":"Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120","volume":"326","author":"Chen","year":"2009","journal-title":"Science"},{"key":"10.1074\/jbc.M117.807396_bib51","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","author":"Collaborative Computational Project, Number 4","year":"1994","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M117.807396_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M117.807396_bib53","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M117.807396_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M117.807396_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820339016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820339016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M117.807396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T13:08:57Z","timestamp":1639832937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820339016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":55,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0021925820339016"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m117.807396","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M117.807396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}